Literature DB >> 31106315

X-ray-activated nanosystems for theranostic applications.

Xiaofeng Chen1, Jibin Song, Xiaoyuan Chen, Huanghao Yang.   

Abstract

X-rays are widely applied in clinical medical facilities for radiotherapy (RT) and biomedical imaging. However, the sole use of X-rays for cancer treatment leads to insufficient radiation energy deposition due to the low X-ray attenuation coefficients of living tissues and organs, producing unavoidable excessive radiation doses with serious side effects to healthy body parts. Over the past decade, developments in materials science and nanotechnology have led to rapid progress in the field of X-ray-activated tumor-targeting nanosystems, which are able to tackle even systemic tumors and relieve the burden of exposure to large radiation doses. Additionally, novel imaging contrast agents and techniques have also been developed. In comparison with conventional external light sources (e.g., near infrared), the X-ray technique is ideal for the activation of nanosystems for cancer treatment and biomedical imaging applications due to its nearly unlimited penetration depth in living tissues and organisms. In this review, we systematically describe the interaction mechanisms between X-rays and nanosystems, and provide an overview of X-ray-sensitive materials and the recent progress on X-ray-activated nanosystems for cancer-associated theranostic applications.

Entities:  

Year:  2019        PMID: 31106315     DOI: 10.1039/c8cs00921j

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  32 in total

Review 1.  Nanoparticle contrast agents for X-ray imaging applications.

Authors:  Jessica C Hsu; Lenitza M Nieves; Oshra Betzer; Tamar Sadan; Peter B Noël; Rachela Popovtzer; David P Cormode
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-05-22

2.  Glycosylated phospholipid-coated upconversion nanoparticles for bioimaging of non-muscle invasive bladder cancers.

Authors:  Bowen Sun; Sneha Sree Mullapudi; Yong Zhang; Koon Gee Neoh
Journal:  Mikrochim Acta       Date:  2022-08-25       Impact factor: 6.408

3.  Composition tunability of semiconductor radiosensitizers for low-dose X-ray induced photodynamic therapy.

Authors:  Lei Chen; Jinghui Zhang; Lihua Xu; Luchao Zhu; Jinpeng Jing; Yushuo Feng; Zongzhang Wang; Peifei Liu; Wenjing Sun; Xiangmei Liu; Yimin Li; Hongmin Chen
Journal:  J Nanobiotechnology       Date:  2022-06-21       Impact factor: 9.429

4.  Breaking photoswitch activation depth limit using ionising radiation stimuli adapted to clinical application.

Authors:  Alban Guesdon-Vennerie; Patrick Couvreur; Fatoumia Ali; Frédéric Pouzoulet; Christophe Roulin; Immaculada Martínez-Rovira; Guillaume Bernadat; François-Xavier Legrand; Claudie Bourgaux; Cyril Lucien Mazars; Sergio Marco; Sylvain Trépout; Simona Mura; Sébastien Mériaux; Guillaume Bort
Journal:  Nat Commun       Date:  2022-07-14       Impact factor: 17.694

5.  Magnetoelectric dissociation of Alzheimer's β-amyloid aggregates.

Authors:  Jinhyeong Jang; Chan Beum Park
Journal:  Sci Adv       Date:  2022-05-11       Impact factor: 14.957

6.  Stimuli-Responsive Plasmonic Assemblies and Their Biomedical Applications.

Authors:  Qinrui Fu; Zhi Li; Fengfu Fu; Xiaoyuan Chen; Jibin Song; Huanghao Yang
Journal:  Nano Today       Date:  2020-11-08       Impact factor: 20.722

7.  Functionalized Scintillating Nanotubes for Simultaneous Radio- and Photodynamic Therapy of Cancer.

Authors:  Irene Villa; Chiara Villa; Roberta Crapanzano; Valeria Secchi; Massimo Tawfilas; Elena Trombetta; Laura Porretti; Andrea Brambilla; Marcello Campione; Yvan Torrente; Anna Vedda; Angelo Monguzzi
Journal:  ACS Appl Mater Interfaces       Date:  2021-03-15       Impact factor: 9.229

Review 8.  Versatile Nanoplatforms with enhanced Photodynamic Therapy: Designs and Applications.

Authors:  Kai Yan; Yabin Zhang; Chenglong Mu; Qunna Xu; Xunan Jing; Daquan Wang; Dongfeng Dang; Lingjie Meng; Jianzhong Ma
Journal:  Theranostics       Date:  2020-06-05       Impact factor: 11.556

9.  The contrast agent 2,3,5-triiodobenzoic acid (TIBA) induces cell death in tumor cells through the generation of reactive oxygen species.

Authors:  Jéssica Sodré Silva de Abreu; Janaína Fernandes
Journal:  Mol Biol Rep       Date:  2021-07-01       Impact factor: 2.316

10.  Low Dose Soft X-Ray Remotely Triggered Lanthanide Nanovaccine for Deep Tissue CO Gas Release and Activation of Systemic Anti-Tumor Immunoresponse.

Authors:  Youbin Li; Mingyang Jiang; Zhiming Deng; Songjun Zeng; Jianhua Hao
Journal:  Adv Sci (Weinh)       Date:  2021-04-08       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.